During the past decade, Investigative Clinical Research of Indiana, LLC conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Investigative Clinical Research of Indiana, LLC" are "Cardiovascular Disease" (2 trials), "Diabetic Nephropathies" (1 trials), "Irritable Bowel Syndrome" (1 trials) and "Migraine" (1 trials). Many other conditions were trialed in "Investigative Clinical Research of Indiana, LLC" in a lesser frequency.

Most popular intervention types in "Investigative Clinical Research of Indiana, LLC" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "Galcanezumab" (1 trials) and "PF-00489791" (1 trials). Other intervention names were less common.

The vast majority of trials in "Investigative Clinical Research of Indiana, LLC" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Investigative Clinical Research of Indiana, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Investigative Clinical Research of Indiana, LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Investigative Clinical Research of Indiana, LLC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".